Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics

D’Souza S. Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2015;27:222–40.

Article  PubMed  PubMed Central  Google Scholar 

de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365–72.

Article  PubMed  PubMed Central  Google Scholar 

Kairys N, J MD, Garg M. Acute subarachnoid hemorrhage. Treasure Island (FL): StatPearls; 2022.

Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016;20:277.

Article  PubMed  PubMed Central  Google Scholar 

Bayer Pharmaceuticals Corporation. NIMOTOP (nimodipine) CAPSULES for oral use: US Food and Drug Administration, 2005 [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018869s014lbl.pdf.

Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S. Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2016;25:29–39.

Article  CAS  PubMed  Google Scholar 

Wessell A, Kole MJ, Badjatia N, Parikh G, Albrecht JS, Schreibman DL, et al. High Compliance with Scheduled Nimodipine Is Associated with Better Outcome in Aneurysmal Subarachnoid Hemorrhage Patients Cotreated with Heparin Infusion. Front Neurol. 2017;8:268.

Article  PubMed  PubMed Central  Google Scholar 

Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al. Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–24.

Article  CAS  PubMed  Google Scholar 

Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68:505–17.

Article  CAS  PubMed  Google Scholar 

Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir. 1986;82:110–4.

Article  CAS  PubMed  Google Scholar 

Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins FS, Mansoura MK. The human genome project. Revealing the shared inheritance of all humankind. Cancer. 2001;91:221–5.

Article  CAS  PubMed  Google Scholar 

Goldstein ED, Badi MK, Hasan TF, Lesser ER, Hodge DO, Lin MP, et al. Cerebral small vessel disease burden and all-cause mortality: Mayo clinic florida familial cerebrovascular diseases registry. J Stroke Cerebrovasc Dis. 2019;28:104285.

Article  PubMed  Google Scholar 

Zhao Y, Zhai D, He H, Li T, Chen X, Ji H. Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort. Eur J Clin Pharmacol. 2009;65:579–84.

Article  CAS  PubMed  Google Scholar 

Mahmoud SH, Ji X, Isse FA. Nimodipine pharmacokinetic variability in various patient populations. Drugs R D. 2020;20:307–18.

Article  PubMed  PubMed Central  Google Scholar 

van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.

Article  PubMed  Google Scholar 

Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832–8.

Article  PubMed  Google Scholar 

Klomp SD, Manson ML, Guchelaar HJ, Swen JJ. Phenoconversion of cytochrome P450 metabolism: a systematic review. J Clin Med. 2020;9:2890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.

Article  CAS  PubMed  Google Scholar 

Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6.

Duello KM, Nagel JP, Thomas CS, Blackshear JL, Freeman WD. Relationship of troponin T and age- and sex-adjusted BNP Elevation following subarachnoid hemorrhage with 30-day mortality. Neurocrit Care. 2015;23:59–65.

Article  CAS  PubMed  Google Scholar 

Parcha V, Heindl BF, Li P, Kalra R, Limdi NA, Pereira NL, et al. Genotype-guided P2Y(12) inhibitor therapy after percutaneous coronary intervention: a Bayesian analysis. Circ Genom Precis Med. 2021;14:e003353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muck W, Ahr G, Kuhlmann J. Nimodipine. Potential for drug-drug interactions in the elderly. Drugs Aging. 1995;6:229–42.

CAS  PubMed  Google Scholar 

James CL, Turnbull MT, Freeman WD. Nimodipine-induced junctional bradycardia in an elderly patient with subarachnoid hemorrhage. Pharmacogenomics. 2020;21:387–92.

Article  CAS  PubMed  Google Scholar 

Peacock SH, James C, Turnbull MT, Cowart JB, Reid JM, Freeman WD. Pharmacogenomics of cytochrome P450 of nimodipine metabolism after aneurysmal subarachnoid hemorrhage. J Neurosci Nurs. 2019;51:238–42.

Article  PubMed  Google Scholar 

Kongable GL, Lanzino G, Germanson TP, Truskowski LL, Alves WM, Torner JC, et al. Gender-related differences in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1996;84:43–8.

Article  CAS  PubMed  Google Scholar 

Abboud T, Andresen H, Koeppen J, Czorlich P, Duehrsen L, Stenzig J, et al. Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2015;157:763–7.

Article  PubMed  Google Scholar 

Tallarico RT, Pizzi MA, Freeman WD. Investigational drugs for vasospasm after subarachnoid hemorrhage. Expert Opin Investig Drugs. 2018;27:313–24.

Article  CAS  PubMed  Google Scholar 

Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet. 1994;26:144–60.

Article  CAS  PubMed  Google Scholar 

Carlson AP, Hanggi D, Macdonald RL, Shuttleworth CW. Nimodipine reappraised: an old drug with a future. Curr Neuropharmacol. 2020;18:65–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burrell C, Avalon NE, Siegel J, Pizzi M, Dutta T, Charlesworth MC, et al. Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia. Expert Rev Neurother. 2016;16:1251–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif